Zimmer Biomet Holdings (ZBH) Cash from Operations (2009 - 2026)

Zimmer Biomet Holdings has reported Cash from Operations for 18 years, with the latest figure at $447.8 million in Q2 2026.

• On a quarterly basis, Cash from Operations rose 18.4% year-over-year to $447.8 million in Q2 2026; TTM through Jun 2026 was $1.7 billion, a 4.83% increase from a year earlier, with the FY2025 full-year figure at $1.7 billion, up 13.19% from the prior year.
• Cash from Operations was $447.8 million for Q2 2026 at Zimmer Biomet Holdings, up from $359.4 million in the prior quarter.
• The five-year high for Cash from Operations was $588.4 million in Q4 2023, with the low at $228.0 million in Q1 2024.
• Average Cash from Operations over 5 years is $385.6 million, with a median of $373.8 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Cash from Operations dropped 27.67% in 2022, then surged 140.95% in 2023.
• Over 5 years, Cash from Operations stood at $244.2 million in 2022, then soared by 140.95% to $588.4 million in 2023, then dropped by 13.95% to $506.3 million in 2024, then gained by 2.19% to $517.4 million in 2025, then slipped by 13.45% to $447.8 million in 2026.
• The last three Cash from Operations figures came in at $447.8 million (Q2 2026), $359.4 million (Q1 2026), and $517.4 million (Q4 2025), per Business Quant data.